3 results
1. To define the optimal pharmacokinetic tracer model for [18F]afatinib. 2. To determine the optimal simplified measure for quantifying tumor [18F]afatinib uptake 3. To assess [18F]afatinib uptake differences between patients (1) with wild type EGFR…
The hypothesis is that a switch from intravenous to oral antimicrobial therapy is non-inferior to standard intravenous therapy in patients with low-risk SAB. Therefore, the primary objective of the trial is to demonstrate, that oral switch therapy (…
To assess the usefulness of NBI in the visualisation of PVs in Western BE patients (in this study using the new Excera III NBI-system), to investigate the discordance between the Japanese and Western definition of de distal end of the Barrett*s…